Updated:
Zhidao Capital
Zhidao Capital is a private equity firm based in China. It invests in growth and mature companies in new energy, biopharmaceutical, and other industries.
Zhidao Capital
Zhidao Capital is a private equity firm based in China. It invests in growth and mature companies in new energy, biopharmaceutical, and other industries. The firm has made 32 investments, including a Seed VC investment in Xien Technology on October 22, 2025.
General information
Firm type
Private Equity
Year founded
2018
Location
Region
Asia
Country
China
City
Hefei
Corporate office
Hefei, Anhui, China
Sector focus
Frequently asked questions
What stage does Zhidao Capital invest at?
Zhidao Capital invests from seed through growth stages, with strategy classifications indicating a focus on early-stage start-ups. The firm's willingness to write first checks into pre-revenue companies suggests a portfolio construction weighted toward seed and Series A rounds. Growth-stage follow-ons imply the capacity to reserve capital for later-dilution protection or insider-led rounds.
Is Zhidao Capital affiliated with the University of Science and Technology of China?
Zhidao is not formally a university venture arm but operates in close geographic and thematic proximity to USTC, one of China's premier research institutions located in Hefei. The firm's strategy of commercializing lab-stage technologies aligns with the university's spinout pipeline, particularly in quantum computing, AI, and advanced materials. No official joint venture or exclusive partnership is publicly documented.
Does Zhidao Capital raise capital from foreign LPs?
The firm's minimal English-language presence and lack of international marketing materials suggest it does not actively solicit capital from non-Chinese limited partners. Its investor base likely consists of domestic institutional LPs, provincial government guidance funds, and potentially high-net-worth individuals connected to the Anhui region's industrial base.
What types of companies does Zhidao Capital invest in?
The firm targets hard-tech enterprises in enterprise software, industrial AI, and advanced semiconductors. Portfolio companies typically originate from China's national research system — spinouts commercializing intellectual property developed inside state-backed laboratories. The investment thesis centers on translating publicly funded R&D into defensible commercial franchises, often in sectors prioritized by China's five-year plans and strategic industrial policy.
How is Zhidao Capital different from other Chinese early-stage venture firms?
Zhidao's differentiation lies in its geographic and institutional adjacency to Hefei's Comprehensive National Science Center, which houses a concentration of quantum computing, AI, and materials science laboratories unmatched outside Beijing. While most Chinese venture firms cluster in Beijing, Shanghai, and Shenzhen competing for the same software and consumer deals, Zhidao accesses a narrower but less-crowded pipeline of deep-tech spinouts from researchers who face fewer term-sheet options and longer commercial paths.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: